Cargando…

A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma

BACKGROUND: Thrombocytosis is triggered by and promotes tumor growth. The relationship between the change in circulating platelets after chemoradiation therapy (CRT) or adjuvant temozolomide (TMZ) and survival in glioblastoma remains unclear. We hypothesized that an increase in platelets after these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boonyawan, Keeratikarn, Hess, Kenneth R., Yang, Jie, Long, Lihong, Wang, Qianghu, Ezhilarasan, Ravesanker, Auia, Alessandra, Alfaro-Munoz, Kristin D., de Groot, John F., Bhat, Krishna P., Sulman, Erik P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685768/ https://www.ncbi.nlm.nih.gov/pubmed/29163847 http://dx.doi.org/10.18632/oncotarget.21799

Ejemplares similares

PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells
por: Modrek, Aram S., et al.
Publicado: (2022)

Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype
por: Farooqi, Ahsan, et al.
Publicado: (2019)

DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas
por: Yang, Jie, et al.
Publicado: (2022)

Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF(V600E) inhibition resistance in melanoma
por: Zhang, Ze-Yan, et al.
Publicado: (2022)

APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death
por: Wang, Yu, et al.
Publicado: (2017)

EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner
por: Kim, Sung-Hak, et al.
Publicado: (2015)

Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles
por: Stitzlein, Lea M., et al.
Publicado: (2023)

Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2016)

Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells
por: Khan, Sabbir, et al.
Publicado: (2021)

The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells
por: Dong, Jianwen, et al.
Publicado: (2018)

Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma
por: Pradhan, Dinesh, et al.
Publicado: (2019)

Changes in Brain Energy and Membrane Metabolism in Glioblastoma following Chemoradiation
por: Grams, Astrid Ellen, et al.
Publicado: (2021)

Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
por: Mallick, Supriya, et al.
Publicado: (2015)

Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide
por: Faustino, Alexandre Ciuffi, et al.
Publicado: (2020)

Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma
por: Vaugier, Loïg, et al.
Publicado: (2021)

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
por: Derer, Anja, et al.
Publicado: (2016)

CDK4/6 inhibition is more active against the glioblastoma proneural subtype
por: Li, Ming, et al.
Publicado: (2017)

Revealing radiotherapy- and chemoradiation-induced pathway dynamics in glioblastoma by analyzing multiple differential networks
por: Zhou, Jia, et al.
Publicado: (2017)

ACT-10 TREATMENT FOR GLIOBLASTOMA RECURRED AFTER CONCOMITANT CHEMORADIATION THERAPY WITH TEMOZOLOMIDE AND THEIR PROGNOSIS
por: Mori, Kanji, et al.
Publicado: (2019)

Application of Machine Learning to Metabolomic Profile Characterization in Glioblastoma Patients Undergoing Concurrent Chemoradiation
por: Aboud, Orwa, et al.
Publicado: (2023)

CD24 and Nanog expression in Stem Cells in Glioblastoma: Correlation with Response to Chemoradiation and Overall Survival
por: Soni, Priyanka, et al.
Publicado: (2017)

Effect of Cumulative Dexamethasone Dose during Concomitant Chemoradiation on Lymphopenia in Patients with Newly Diagnosed Glioblastoma
por: Lee, Changik, et al.
Publicado: (2020)

Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis
por: Wee, Chan Woo, et al.
Publicado: (2020)

TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1
por: Hossain, Mohammad B., et al.
Publicado: (2016)

Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma
por: Maralani, Pejman Jabehdar, et al.
Publicado: (2021)

Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
por: Wu, Lingxiang, et al.
Publicado: (2023)

Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
por: Ly, K. Ina, et al.
Publicado: (2018)

Improved dosimetric accuracy with semi‐automatic contour propagation of organs‐at‐risk in glioblastoma patients undergoing chemoradiation
por: Lee, Sangjune, et al.
Publicado: (2019)

Exploratory Analysis of Serial (18)F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma
por: Fatania, Kavi, et al.
Publicado: (2022)

Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort Analysis
por: Stewart, James, et al.
Publicado: (2022)

Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma
por: Adeberg, Sebastian, et al.
Publicado: (2015)

Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation
por: Shidoh, Satoka, et al.
Publicado: (2022)

Proteomic analysis of platelet-rich and platelet-poor plasma
por: Miroshnychenko, Olga, et al.
Publicado: (2020)

Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation
por: Naumann, Patrick, et al.
Publicado: (2019)

Real world clinical outcomes of adjuvant sequential chemoradiation in patients with gallbladder carcinomas with poor performance status
por: Kapoor, Rakesh, et al.
Publicado: (2020)

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
por: Batchelor, Tracy T, et al.
Publicado: (2023)

Mean Platelet Volume/Platelet Count Ratio and Risk of Progression in Glioblastoma
por: Wach, Johannes, et al.
Publicado: (2021)

Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
por: Ly, K. Ina, et al.
Publicado: (2019)

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
por: Corradetti, Michael N., et al.
Publicado: (2019)

High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers
por: Lin, Shih-Chun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7qq5qs0g9kuee6j82oljlolu1d